Comparison of Serum Bone Resorption Markers in the Diagnosis of Skeletal Metastasis

Anticancer Research

Volumn 23, Issue 5 B, 2003, Pages 4095-4099

  Koizumi, Mitsuru ^a   Takahashi, Shunji ^a   Ogata, Etsuro ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Bone resorption markers; ICTP; NTx; Skeletal metastasis; TRAP5b

Indexed keywords

BIOCHEMICAL MARKER; BIOLOGICAL MARKER; N TERMINAL CROSS LINKED TELOPEPTIDE OF TYPE 1 COLLAGEN; PROCOLLAGEN C PROTEINASE; PROCOLLAGEN N PROTEINASE; PYRIDINOLINE CROSS LINKED CARBOXY TERMINAL TELOPEPTIDE OF TYPE 1 COLLAGEN; TARTRATE RESISTANT ACID PHOSPHATASE TYPE 5B; UNCLASSIFIED DRUG;

ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ROC CURVE;

ACID PHOSPHATASE; BONE NEOPLASMS; BONE RESORPTION; BREAST NEOPLASMS; COLLAGEN; COLLAGEN TYPE I; FEMALE; GLYCOPROTEINS; HUMANS; ISOENZYMES; LUNG NEOPLASMS; MALE; PEPTIDES; PROSTATIC NEOPLASMS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 0344872699     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. American Society of Clinical Oncology. Recommended breast cancer surveillance guidelines. J Clin Oncol 15: 2149-2156, 1997.
2. Calvo MS, Eyre DR and Gundberg CM: Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev 17: 333-368, 1996.
3. Koizumi M and Ogata E: Bone metabolic markers as gauges of metastasis to bone: a review. Ann Nucl Med 16: 161-168, 2002.
4. Nishi Y, Atley L, Eyre DE, Edelson JG, Superti-Furga A, Yasuda T, Desnick RJ and Gelb BL: Determination of bone markers in Pycnodysostosis: Matrix degradation. J Bone Miner Res 14: 1902-1908, 1999.
5. Atley LM, Mort JS, Lalumiere M and Eyre DR: Proteolysis of human collagen by cathepsin K: Characterization of the cleavage sites generating the cross-linked N-telopeptide neoepitope. Bone 26: 241-247, 2000.
6. Sassi ML, Eriksen H, Risteli L, Niemi S, Mansell J, Gowen M and Risteli J: Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: Loss of antigenecity by treatment with cathepsin K. Bone 26; 367-373, 2000.
7. Halleen JM, Alatalo SL, Suominen H, Cheng S, Janckila AJ and Vaananen K: Tartrate-resistant acid phosphatase 5b: A novel serum marker of bone resorption. J Bone Miner Res 15: 1337-1345, 2000.
8. Demers LM, Costa L, Chinchilli VM, Gaydos L, Curley E and Lipton A: Biochemical markers of bone turnover in patients with metastatic bone disease. Clin Chem 41: 1489-1494, 1995.
9. Costa L, Demers LM, Gouveria-Oliveira A, Schaller J, Costa EB, de Moura MC and Lipton A: Prospective evaluation of the peptide-bound collagen type I cross-links N-telopeptide and C-telopeptide in predicting bone metastases status. J Clin Oncol 20: 850-857, 2002.
10. Soloway MS, Hardeman SW, Hickey D, Raymond J, Todd B, Soloway S and Moinuddin M: Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer 61: 195-202, 1988.
11. Clemens JD, Herrick MV, Singer FR and Eyre DR: Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption. Clin Chem 43: 2058-2063, 1997.
12. Maeda H, Koizumi M, Yoshimura K, Yamauchi T, Kawai T and Ogata E: Correlation of bone metabolic markers and bone scan in prostate cancer. J Urol 157: 539-543, 1997.
13. Garnero P, Shin WJ, Gineyts E, Karpf DB and Dermas PD: Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 79: 1693-1700, 1994.
14. Koizumi M, Takahashi S and Ogata E: Bone metabolic marker in bone metastasis of breast cancer. Int. J Clin Oncol 4: 241-246, 1999.